Connect by Circular-Lab

Solutions

Connected against cancer

CLAB bridges the Gaps in the Era of Precision Medicine

  • CLAB is the first AI (Artificial Intelligence) platform that digitizes, centralizes and structures clinical diagnostics and health data using Machine Learning (ML) and Natural Language Processing (NLP).
  • It simplifies data collection, integration and reporting standardization and increases transparency and traceability of patient data.
  • It connects and benefits all the stakeholders in the testing pathway.

Created by experts in diagnosis.

Prioritizing areas with impact, like oncology biomarkers.

With versatile digital and Big Data tools.

Already implemented in Spain, Italy and France. Global expansion.

CLAB connects and benefits all the stakeholders 
in the testing pathway

CLAB has been designed as a global connectivity platform seeking to integrate all the stakeholders in the cancer treatment value chain. 
This interconnectivity enables to improve quality, training, transparency and communication flow, benefiting the entire ecosystem.

Digitizes, centralizes and structures clinical data

Most information from cancer diagnostic reports, is not structured which leads to the loss or inability to use internal data. 

Circular-Lab digitizes the molecular diagnosis of cancer, acting as a link between the industry and specially, 

The patient

Molecular biology makes it possible to identify the specific genetic mutations that cause a patient’s cancer, and the development of treatments directed at these mutations, which are more effective against the disease.

Favicon Circular-lab

The treatment

The development of precision medicine requires greater integration and visibility of key data for treatment, which facilitates the rapid identification of patients with specific mutations to accelerate the validation and administration of these targeted drugs.

Our aim is to improve the diagnostic and treatment of cancer patients through digitalization

1

Global Connectivity Interoperable Platform

It benefits all stakeholders in the cancer treatment value chain.

It provides them with essential integrated information that is instrumental in guiding patient treatment.

2

Intelligent Database

It is connected to laboratories. It automates, digitizes, structures and centralizes cancer biomarker data.

3

Connection to Clinical Data

It is an essential link to connect the biomarker result to the patient´s clinical outcome (treatment administered and response).

CLAB for Laboratories

Circular-Lab is a valuable tool for laboratories and diagnostic companies. Not only it digitizes and structures data from reports, but also centralizes it (inter and intra), for quality policies and continuous improvement, through real-time monitoring of Dx activities.

Giving therefore, access and exposure to pharma and other stakeholders.

 

Thanks to its integrative and connectivity nature, CLAB allows to monitor positivity ratios for epidemiological purposes, make comparisons between laboratories and to detect deviations in the results, as well as to validate and facilitate quality control and accreditation.

 

CLAB has a very relevant impact on diagnostic laboratories, increasing their efficiency.

CLAB for Professional Societies

Access to country data for comparative analysis, continuous improvement and consensus on cancer treatment protocols and strategies.
Information structured in a reliable and auditable way for high-level scientific disclosures and publications.

CLAB for Industry

CLAB centralizes and structures health information, such as oncology biomarker data, automatically into an intelligent database from multiple cancer indications, biomarker types, turn-around times, positivity rates, installed based and other parameters.
This database contains highly valuable Real-World Data (RWD) for all the stakeholders, being a resourceful tool for Pharmaceutical Companies that are willing to contribute in the fight against cancer.

It would give access to key information in real time, could help reduce drug development times, making them faster in terms of market introduction and adoption, as will be a crucial aid to develope adaptive marketing, reimbursement strategies and adoption of proactive measures based on real time information.

CLAB for Governments & Public Administrations

CLAB for Biobanks

CLAB for CROs

CLAB for Research and Investigation​